ORIG3N orig3n.com


Public list: CES 2016 (629) BIO 2016 (619) CES 2017 Exhibitors (608) Pharma Startups (4524)

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver and neurodegenerative indications. These treatments are based upon Nobel Prize winning technology. This will replace the trial & error guess work of treating disease and enable longer, healthier lives.

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver and neurodegenerative indications. These treatments are based upon Nobel Prize winning technology. This will rep...Show all

Company (Alive / Active)

Phone: 800-316-7301

Fax:

27 Drydock Ave
6th Floor
Boston, 02210
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ORIG3N $35.6M Jun 27, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ORIG3N Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 13 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Optical recognition of blood types Dec 16, 2015 Application